PerkinElmer to Expand Neonatal Screening Program in Israel


PerkinElmer, Inc. announced that its neonatal screening technology has been selected by State of Israel's Chaim Sheba Medical Center, Tel Aviv, to create a comprehensive newborn screening program that is intended to cover every child born in Israel. Under the terms of this agreement, PerkinElmer will provide the State of Israel with instrumentation, reagents, scientific expertise, and a robust informatics system that will enhance the nation's neonatal screening and data management capabilities.

The contract, to be executed through PerkinElmer's regional distributors HVD Vertriebs Gmbh and Gamidor Limited, will fulfill a recent mandate by the Medical Research Infrastructure Development and Health Services Fund to substantially expand its newborn screening program to cover Israel's entire population and increase the number of tests that will be screened for indications of disease. Approximately 120,000 babies are born each year in Israel, which has a population of about 6.3 million.

Other news from the department business & finance

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy